Aussie medical tech scores big win in US market

Cyclopharm’s lung imaging technology is breathing new life into the company’s bottom line, with its Technegas product surpassing the million-dollar milestone in US sales, according to Tuesday’s ASX announcement. The Sydney-based company has rapidly expanded its American footprint, with Technegas systems now installed in 27 US medical facilities as of 31 March 2025 – a…

Call for homegrown medicine production as penicillin imports dry up

A critical shortage of an essential penicillin medication is highlighting Australia’s vulnerability in pharmaceutical manufacturing, according to a new report published in the Medical Journal of Australia on Monday. The medication, benzathine benzylpenicillin G (BPG), is vital for treating syphilis and preventing rheumatic heart disease, conditions that disproportionately affect Aboriginal and Torres Strait Islander communities.…

WA gov to kickstart medical start-ups

The West Australian government has provided $4.3 million in seed funding for health and medical start-ups to boost the sector’s manufacturing in the state. Nine companies will receive support from the 2022-23 Future Health Research and Innovation (FHRI) Fund Innovation Seed Fund, which will help them develop and commercialise their projects, as well as enhance…